Talquetamab with daratumumab for treating relapsed or refractory multiple myeloma after 1 or more treatments ID6625

  • In development
  • GID-TA11815
  • Expected publication date: TBC

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6625